TNXP

Tonix Pharmaceuticals Holding Corp.

Insiders buying nowCIK 1430306

Tonix Pharmaceuticals Holding Corp. insider trading

Insiders at Tonix Pharmaceuticals Holding Corp. have been buying its stock on the open market. The largest purchase in the last 30 days was Lederman Seth (Chief Executive Officer · Director) buying $27.6K of TNXP, filed Aug 31, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.

Bought on the open market
$27.6K
Sold
Insiders
1
Latest trade
Aug 27, 2026

From SEC filings · last 30 days

Recent TNXP insider transactions

  1. Lederman SethChief Executive Officer · Director

    Bought 2,000 sh at $13.79 · Aug 27, 2026

    $27.6K

    Filing

SEC Form 4 data, Q3 2024 to Q2 2026

TNXP insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded TNXP on the open market: 8 purchases worth $528.8K and 0 sales. In the last four quarters alone: 7 purchases ($442.6K) and 0 sales, by 4 insiders.

QuarterBoughtSold
Q2 2026+$132.1K3 buys
Q1 2026+$286.5K2 buys
Q4 2025
Q3 2025+$24.1K2 buys
Q2 2025+$86.2K1 buy
Q1 2025
Q4 2024
Q3 2024
Largest purchase
+$223.4K of TNXP by Lederman Seth (Chief Executive Officer · Director) on Mar 18, 2026.

Open-market transactions through Jun 30, 2026most recent first

  • Taylor Carolyn E.

    Director

    +$14.9K

    Jun 12, 2026

    1,415 sh · $10.55

  • Lederman Seth

    Chief Executive Officer · Director

    +$59K

    Jun 09, 2026

    5,000 sh · $11.79

  • Stillwell Richard Newcomb

    Director

    +$58.3K

    Jun 08, 2026

    5,000 sh · $11.65

  • Lederman Seth

    Chief Executive Officer · Director

    +$63.1K

    Mar 31, 2026

    5,000 sh · $12.62

  • Lederman Seth

    Chief Executive Officer · Director

    +$223.4K

    Mar 18, 2026

    15,000 sh · $14.89

  • Taylor Carolyn E.

    Director

    +$15.1K

    Aug 21, 2025

    418 sh · $36.03

  • Treco James

    Director

    +$9K

    Aug 20, 2025

    250 sh · $36.00

  • Lederman Seth

    Chief Executive Officer · Director

    +$86.2K

    May 15, 2025

    4,000 sh · $21.55

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Don't check TNXP — let it ping you

Watch every insider filing the minute it clears the SEC

The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.

Tonix Pharmaceuticals Holding Corp. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.

Other companies insiders are buying now

Questions

Are TNXP insiders buying or selling?
Between Aug 27, 2026 and Aug 27, 2026, 1 Tonix Pharmaceuticals Holding Corp. insider made 1 open-market purchase worth $27.6K and no sales, a net purchase of $27.6K.
How much TNXP stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 4 Tonix Pharmaceuticals Holding Corp. insiders made 8 open-market purchases worth $528.8K and no sales. In the four quarters to Jun 30, 2026: 7 purchases ($442.6K) and no sales. The largest purchase was Lederman Seth buying $223.4K on Mar 18, 2026.
What was the largest recent TNXP insider trade?
Lederman Seth (Chief Executive Officer · Director) bought $27.6K of TNXP stock on Aug 27, 2026 at about $13.79 a share.
When did an insider last buy TNXP shares?
The most recent open-market purchase on file is Lederman Seth (Chief Executive Officer · Director) buying $27.6K on Aug 27, 2026.
Where does TNXP insider trading data come from?
From the Form 4 filings Tonix Pharmaceuticals Holding Corp.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

The week's real signals — open-market insider buys, cluster formations and what insiders did in TNXP and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.

Sign up free